Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | DGKA | P23743 | 2/20 | 0.47 |
| ▸ | PRKCA | P17252 | 2/20 | 0.45 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.45 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.45 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.45 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5345531 | 0.94 | MGLL (0.62) | MGLLDNM1EPHX2ALDH1A1DGKA | |
| SCHEMBL5345533 | 0.94 | MGLL (0.62) | MGLLDNM1EPHX2ALDH1A1DGKA | |
| SCHEMBL19519105 | 0.91 | MGLL (0.45) | MGLLDNM1EPHX2ALDH1A1CYP3A4 | |
| SCHEMBL5868436 | 0.88 | DNM1 (0.69) | MGLLDNM1EPHX2ALDH1A1ALOX15 | |
| SCHEMBL10062013 | 0.88 | DNM1 (0.51) | MGLLDNM1EPHX2ALDH1A1CYP3A4 | |
| SCHEMBL5868433 | 0.88 | DNM1 (0.69) | MGLLDNM1EPHX2ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL5868346 | 0.86 | DNM1 (0.67) | MGLLDNM1EPHX2ALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL5868342 | 0.86 | DNM1 (0.67) | MGLLDNM1EPHX2ALDH1A1ALOX15 | |
| SCHEMBL4399170 | 0.86 | MGLL (0.50) | MGLLDNM1EPHX2ALDH1A1CYP3A4 | |
| SCHEMBL4406504 | 0.85 | DNM1 (0.70) | MGLLDNM1EPHX2ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2633022-B1 | HARD SURFACE CLEANERS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2019-01-23 | — | — | EP | disclosed |
| US-9796662-B2 | Esteramines and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2017-10-24 | — | — | US | disclosed |
| US-9796662-B2 | Esteramines and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2017-10-24 | — | — | US | disclosed |
| US-9303234-B2 | Hard surface cleaners based on compositions derived from natural oil metathesis | STEPAN COMPANY (US) | 2016-04-05 | — | — | US | disclosed |
| US-9303234-B2 | Hard surface cleaners based on compositions derived from natural oil metathesis | STEPAN COMPANY (US) | 2016-04-05 | — | — | US | disclosed |
| US-20160023989-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2016-01-28 | — | — | US | disclosed |
| US-20160023989-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2016-01-28 | — | — | US | disclosed |
| US-9187711-B2 | Esteramines and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2015-11-17 | — | — | US | disclosed |
| US-9187711-B2 | Esteramines and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2015-11-17 | — | — | US | disclosed |
| US-20130225469-A1 | HARD SURFACE CLEANERS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225859-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225469-A1 | HARD SURFACE CLEANERS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225859-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| WO-2012061093-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012061103-A2 | HARD SURFACE CLEANERS BASED ON COMPOSITONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225859-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | SOAT2, SOAT1, SGMS1 | MGLL 144/4885DNM1 3483/4885EPHX2 551/4885 |
| US-20160023989-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | SOAT2, SOAT1, SGMS1 | MGLL 144/4885DNM1 3483/4885EPHX2 551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.